FDA Grants Orphan Drug Designation To ImmunoGen IMGN901 Compound
Through a separate process, the EU Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC. IMGN901 is an
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.